Literature DB >> 18380703

Warfarin-induced allergic interstitial nephritis and leucocytoclastic vasculitis.

K G Kapoor1, T Bekaii-Saab.   

Abstract

Warfarin sodium has been associated with leucocytoclastic vasculitis and has once been associated with allergic interstitial nephritis. Hypersensitivity to warfarin sodium simultaneously resulting in allergic interstitial nephritis and leucocytoclastic vasculitis has not yet been previously reported. We present a 48-year-old man who was on warfarin sodium for 2 months and presented with acute renal failure and reddish purplish macules on his hypogastric regions and lower extremities bilaterally. Kidney biopsy showed allergic interstitial nephritis and punch skin biopsy showed leucocytoclastic vasculitis. Both biopsies also showed high eosinophil count, highly suggestive of a drug-induced reaction. After a negative comprehensive work-up and the absence of other recent medication changes, our patient was determined to have allergic interstitial nephritis and leucocytoclastic vasculitis secondary to warfarin sodium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18380703     DOI: 10.1111/j.1445-5994.2008.01646.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  14 in total

Review 1.  Drug-induced tubulointerstitial nephritis: hypersensitivity and necroinflammatory pathways.

Authors:  Allison A Eddy
Journal:  Pediatr Nephrol       Date:  2019-02-28       Impact factor: 3.714

2.  Supratherapeutic International Normalized Ratio causing Nephropathy: A Rare Adverse Effect of Warfarin.

Authors:  Muhammad Shabbir Rawala; Amna Saleem Ahmed; Muhammad Y Khan; Muhammad Nauman Riaz; Amr Eltoukhy
Journal:  Cureus       Date:  2019-07-22

Review 3.  Pathogenesis of glomerular haematuria.

Authors:  Claudia Yuste; Eduardo Gutierrez; Angel Manuel Sevillano; Alfonso Rubio-Navarro; Juan Manuel Amaro-Villalobos; Alberto Ortiz; Jesus Egido; Manuel Praga; Juan Antonio Moreno
Journal:  World J Nephrol       Date:  2015-05-06

4.  Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate.

Authors:  Sergey V Brodsky; Tibor Nadasdy; Brad H Rovin; Anjali A Satoskar; Gyongyi M Nadasdy; Haifeng M Wu; Udayan Y Bhatt; Lee A Hebert
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

5.  Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease.

Authors:  Sergey V Brodsky; Michael Collins; Edward Park; Brad H Rovin; Anjali A Satoskar; Gyongyi Nadasdy; Haifeng Wu; Udayan Bhatt; Tibor Nadasdy; Lee A Hebert
Journal:  Nephron Clin Pract       Date:  2010-04-22

Review 6.  Oral anticoagulants and risk of nephropathy.

Authors:  Vinay Narasimha Krishna; David G Warnock; Nakshatra Saxena; Dana V Rizk
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

7.  Renal function in patients with mechanical prosthetic valves : Long-term effects of anticoagulation and over-anticoagulation with warfarin.

Authors:  Yiğit Çanga; Tolga Sinan Güvenç; Ali Nazmi Çalık; Mehmet Baran Karataş; Evliya Akdeniz; Gizem Yüksel; Ayşe Emre
Journal:  Wien Klin Wochenschr       Date:  2018-06-04       Impact factor: 1.704

8.  Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin.

Authors:  Gilbert W Moeckel; Randy L Luciano; Ursula C Brewster
Journal:  Clin Kidney J       Date:  2013-09-10

9.  Whether Warfarin Therapy is Associated with Damage on Renal Function in Chinese Patients with Nonvalvular Atrial Fibrillation.

Authors:  Yu Kong; Xin Du; Ri-Bo Tang; Ting Zhang; Xue-Yuan Guo; Jia-Hui Wu; Shi-Jun Xia; Chang-Sheng Ma
Journal:  Chin Med J (Engl)       Date:  2016-05-20       Impact factor: 2.628

10.  Warfarin-induced leukocytoclastic vasculitis and proteinuria.

Authors:  Khalid Jumean; Ahmad Abu Arqoub; Amer Hawatmeh; Firas Qaqa; Ayham Bataineh; Hamid Shaaban
Journal:  J Family Med Prim Care       Date:  2016 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.